Exhibit 99




|For immediate release: | Media Contact:      
|---------------------- | --------------------
|August 22, 2007        | Ray Kerins          
|                       | (212) 733-9203      
|                       | Investor Development
|                       | Suzanne Harnett     
|                       | (212) 733-8009      

> PFIZER NAMES FRANK A. D'AMELIO CHIEF FINANCIAL
>       OFFICER
>       ---Brings Extensive Operating and Financial Experience in Global
>       Companies Undergoing Rapid Change
>     NEW YORK, August 22 -- Pfizer today announced that Frank A.
>       D'Amelio, a senior executive with almost three decades of extensive operating
>       and financial experience at AT&T, Lucent Technologies and Alcatel-Lucent,
>       including serving as both chief operating officer and chief financial officer
>       at Lucent, will become Pfizer's Senior Vice President and Chief Financial
>       Officer effective in mid-September.
>     Mr. D'Amelio, who is currently Senior Executive Vice President, Integration
>       and Chief Administrative Officer at Alcatel-Lucent, will join Pfizer's Executive
>       Leadership Team and report to Pfizer Chairman and Chief Executive Officer
>       Jeff Kindler. He will have responsibility for all aspects of the company's
>       finances, including treasury, tax, the controller's division and investor
>       development. He succeeds Alan Levin, whose resignation from Pfizer was announced
>       in May.
>     "We are very pleased that an executive with Frank's skills, integrity,
>       global experience and proven leadership is joining our management team,"
>       said Mr. Kindler. "Through almost three decades at AT&T, Lucent
>       and Alcatel-Lucent in both operating and financial roles, Frank was a senior
>       executive in global companies undergoing the kind of rapid and complex changes
>       we have undertaken at Pfizer in response to our own rapidly changing markets.
>     "He drove product innovations and strong performance in the operating
>       units he led before assuming the role of Lucent's Executive Vice President,
>       Administration and Chief Financial Officer in May 2001, which was early
>       in a period of fundamental change in the global technology markets. Over
>       the next five years he played a crucial role in recapitalizing and restructuring
>       the company, culminating in the 2006 Alcatel-Lucent merger, where he has
>       led the global integration of the two companies. He has extensive knowledge
>       of the capital markets as well as broad experience working with the investment
>       community, regulatory bodies and rating agencies. As CFO, Frank will lead
>       an accomplished team in our Finance division, and I am confident he will
>       bring valuable new perspectives to our business and financial strategies
>       as we continue to respond aggressively to our challenges and opportunities
>       and work to enhance the value of Pfizer."
>     Mr. D'Amelio said, "I am delighted to join Pfizer, a company with
>       outstanding management, great people and what I truly believe is a very
>       promising future in the forefront of medical innovation. In just a short
>       period of time, Jeff has demonstrated strong leadership in setting a course
>       for Pfizer to change the way it does business, so that it will be in the
>       best possible position to take advantage of growing global demand for high-quality
>       healthcare. Together with my finance colleagues, we'll work hard to ensure
>       that all aspects of Pfizer's global financial strategy and operations help
>       to advance these critical business imperatives.
>     "Pfizer is in the business of saving lives through innovative medicines.
>       I can't think of a more important mission, and I look forward to working
>       with my new colleagues and everyone on the management team as we develop
>       and execute plans to enhance Pfizer's competitive advantages and its long-term
>       shareholder value."
>     Mr. Kindler added, "Our Vice Chairman, David Shedlarz, will work closely
>       with Frank, and I know Frank will benefit from David's perspective on all
>       aspects of our business."
>     Mr. Shedlarz leads Pfizer's strategic planning and business development,
>       as well as animal health, manufacturing, information technology, internal
>       audit, operations/facilities and procurement.
>     "Together with Jeff and our entire team, I am committed to ensuring
>       that we execute on our immediate business priorities as well as our new
>       strategy for business development," said Mr. Shedlarz. "Frank
>       is a strong addition to our team and brings a diverse set of skills in global
>       finance and multinational operations that I am sure will be of great value
>       to Pfizer. We know what we need to do to improve our performance and capitalize
>       on the many opportunities we see to drive innovation in healthcare across
>       our global markets."
>     Mr. D'Amelio began his career in 1979 at AT&T Bell Labs, where he held
>       a variety of financial, accounting and general management positions. Before
>       moving into an operations role at Lucent, Frank was Vice President and Chief
>       Financial Officer of Lucent's Network Systems Business. When Lucent was
>       created in 1996, he helped establish the financial structure of the new
>       company and was part of the road show team that met with investors around
>       the world during Lucent's initial public offering. Prior to being named
>       Executive Vice President, Administration and CFO of Lucent in May 2001,
>       Frank was Group President of Lucent's Switching Solutions Group, where he
>       led the manufacturing, research and development, marketing and product management
>       of Lucent's switching, access and applications software businesses, a multi-billion
>       dollar global business.
>     As Lucent's Executive Vice President Administration and Chief Financial
>       Officer from 2001 to 2006, Mr. D'Amelio was responsible for executive management
>       and oversight of all financial, accounting, human resources, law, labor
>       relations and real estate operations of the company. In early 2006 he was
>       appointed Lucent's Chief Operating Officer, responsible for leading the
>       operations of the business including sales, the product groups, the services
>       business, the supply chain, IT operations and labor relations. After Lucent
>       announced its merger with Alcatel later in 2006, Mr. D'Amelio was appointed
>       Senior Executive Vice President, Integration and Chief Administrative Officer.
>     Mr. D'Amelio is a member of the Board of Directors of Humana, Inc. He holds
>       a bachelor's degree in accounting from St. Peter's College and an MBA in
>       finance from St. John's University.
>   # # # # #